Welcome to our dedicated page for Healthstream SEC filings (Ticker: HSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The HealthStream Inc (HSTM) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. HealthStream is a Tennessee corporation whose common stock trades on Nasdaq under the symbol HSTM, and its filings offer detailed insight into its financial condition, corporate actions, and material events.
HealthStream uses Form 8-K to report a variety of significant developments. These include quarterly results of operations and financial condition, where the company discloses revenues, operating income, net income, earnings per share, and adjusted EBITDA, along with updated guidance for the full year. The same filings may describe quarterly cash dividends declared under the company’s dividend policy, including the per-share amount and record and payment dates.
Other 8-K filings document share repurchase authorizations approved by the Board of Directors, specifying the maximum dollar amount of common stock that may be repurchased, the expected duration of the program, and the possible use of open market purchases, Rule 10b5-1 plans, and privately negotiated transactions. HealthStream also files 8-Ks to announce acquisitions, such as the purchases of Virsys12, LLC and MissionCare Collective LLC, and incorporates related press releases by reference.
Through these filings, readers can see how HealthStream reports on its platform and SaaS investments, capital allocation decisions, and expansion of its workforce and provider solutions. On Stock Titan, AI-powered tools can summarize lengthy filings, highlight key items—such as new repurchase programs, dividend declarations, or acquisition details—and help users quickly understand the implications of each disclosure.
Use this page to monitor HealthStream’s official SEC communications, from earnings-related 8-Ks to other material event reports, and to review the company’s ongoing regulatory history in a structured, searchable format.
Jeff Cunningham, Chief Technology Officer of HealthStream, filed a Form 4 reporting an equity award and current stock holdings. The filing shows a grant of 2,069 restricted share units (RSUs) on 09/24/2025, each RSU representing the contingent right to one share of common stock and recorded at a $0 purchase price. The RSUs vest over four years based on continued service: 15% on 09/24/2026, 20% on 09/24/2027, 30% on 09/24/2028, and 35% on 09/24/2029. The form also lists a reported common stock holding of 32,353 shares following the transaction. The filing is signed and dated 09/26/2025.
Michael Scott McQuigg, Senior Vice President and officer of HealthStream, reported transactions on Form 4 for 09/24/2025. The filing shows an award of 2,069 restricted share units (RSUs) granted at $0, each representing the contingent right to receive one share of common stock on vesting. The RSUs follow a four‑year service‑based vesting schedule: 15% on 9/24/2026, 20% on 9/24/2027, 30% on 9/24/2028, and 35% on 9/24/2029. The filing also records a change in non‑derivative common stock holdings showing 27,931 shares with a disposition flag (D). The report is signed 09/26/2025.
Scott Alexander Roberts, CFO and SVP of HealthStream, reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 29,540 shares of common stock and the grant of 2,069 restricted share units (RSUs) on 09/24/2025. Each RSU converts to one share upon vesting under a four‑year schedule: 15% vest 09/24/2026, 20% vest 09/24/2027, 30% vest 09/24/2028 and 35% vest 09/24/2029. The RSUs have a $0 exercise price and are held directly.
Scott Fenstermacher, Senior Vice President at HealthStream, reported insider transactions dated 09/24/2025. The filing records a reported disposal of 16,026 shares of common stock and the acquisition of 1,552 restricted share units (RSUs) granted on 09/24/2025. Each RSU converts to one share upon vesting and the RSUs follow a four-year vesting schedule: 15% on 09/24/2026, 20% on 09/24/2027, 30% on 09/24/2028, and 35% on 09/24/2029. The RSUs were reported as beneficially owned following the transaction: 1,552 shares. The form is signed by Scott Fenstermacher on 09/26/2025.
Form 144 notice for HealthStream, Inc. (HSTM): an individual proposes to sell 2,000 shares of Common Stock through J.P. Morgan Securities LLC on 08/27/2025.
The filing states the shares were acquired as an RSU award from the issuer on 01/08/2025, paid in full on that date, and the reported aggregate market value of the proposed sale is $56,000. The filer reports 29,641,207 shares outstanding and discloses no sales by the holder in the prior three months. The filer certifies no undisclosed material adverse information.
HealthStream Inc. executive Kevin P. O'Hara reported the sale of 2,000 shares of the company's common stock on 08/27/2025, at a weighted average price of $27.9679 per share (individual trades ranged from $27.79 to $28.10). After the sale, Mr. O'Hara beneficially owned 17,137 shares. The Form 4 identifies Mr. O'Hara as an Executive Vice President and officer of the issuer and shows the filing was signed on 08/27/2025. The disclosure includes an agreement to provide trade-level detail on request and contains no derivative transactions or other securities reported on this form.